Invest Now
Samco Star Rating Ads

Alpa Laboratories Ltd Price Performance

  • Day's Low
  • ₹118
  • Day's High
  • ₹123
₹ 118.59
  • 52-w low
  • ₹69.9
  • 52-w high
  • ₹144.5
118.59
  • Day's open
    ₹123
  • Previous close
    ₹120.68
  • VWAP
    ₹118.85
  • Lower price band
    ₹114.64
  • Upper price band
    ₹126.71

Today's Market Action

The last traded share price of Alpa Laboratories Ltd was 118.59 down by -1.73% on the NSE. Its last traded stock price on BSE was 119.00 down by -1.65%. The total volume of shares on NSE and BSE combined was 15,953 shares. Its total combined turnover was Rs 0.19 crores.

Alpa Laboratories Ltd Medium and Long Term Market Action

Alpa Laboratories Ltd hit a 52-week high of 144.5 on 30-09-2024 and a 52-week low of 69.9 on 04-06-2024. The stock price of Alpa Laboratories Ltd is up by 6% over the last one month. It is up by 14.69% over the last one year. Don't forget to check the full stock price history in the table below.

Alpa Laboratories Ltd Fundamentals

  • Market Cap (Cr): 228

  • Book Value (₹):

  • Stock P/E:

  • Revenue (Cr):

  • Total Debt (Cr):

  • Face Value (₹):

  • Roce (%):

  • ROE (%):

  • Earnings (Cr):

  • Promoter’s Holdings (%):

  • EPS (₹):

  • Debt to Equity:

  • Dividend Yield (%):

  • Cash (Cr):

Alpa Laboratories Ltd Mutual fund holdings and trends

FUND NAME Quantity Monthly Change (Qty)

Alpa Laboratories Ltd Shareholding Pattern

Similar Stocks

Company Price Market Cap (Cr) P/E

About Alpa Laboratories Ltd

Data not available.

Alpa Laboratories Ltd FAQ's

What is Share Price of Alpa Laboratories Ltd?

What is the Market Cap of Alpa Laboratories Ltd?

What is PE Ratio of Alpa Laboratories Ltd?

What is PB Ratio of Alpa Laboratories Ltd?

What is the CAGR of Alpa Laboratories Ltd?

How to Buy Alpa Laboratories Ltd Share?

Financials

(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

  • Momentum Strength
    The stock is currently exhibiting strong momentum, & is showing consistent strong relative strength.
  • Asset Light Business
    The company operates a great asset light business with a high Asset turnover ratio of 10.36. A high asset turnover ratio is a great driver of RoE and can improve shareholder returns. A relatively higher asset turnover ratio also will result in lower dilution as the business grows its revenues as earnings.
  • Zero Debt
    The company has almost nil to negligible debt to equity ratio of 0.03. Considering the fact that the business is debt free, equity shareholders shall carry lower risk of holding the stock.
  • Above Average Growth Rate
    The company is estimated to grow its earnings at a reasonable rate over the next few years which will drive shareholder value creation

Cons

  • Low Sustainable RoE
    The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
  • Low Return on Capital Employed
    The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
  • Poor Cash Flow Conversion
    The business has very poor cash conversion ratio of only 17.39% of operating earnings getting converted into operating cash flow. This implies that increase in profits has not translated into higher cash flows for the business and incrementally higher investments in working capital which works negatively for shareholders.
  • Highly Cyclical Industry
    The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
  • Low Pricing Power & High Competition
    The business has extremely low pricing power and is vulnerable to competitive pressure which can significantly impact shareholder returns.
  • Poor Working Capital Cycle
    The company has a very poor working capital cycle of 176 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.

Valuation Analysis

Margin of safety
(19/12/2024)
Stock Valuation
Green line
94
100.00%
100.00% People are bullish about Alpa Laboratories Ltd
0.00%
0.00 % People are bearish about Alpa Laboratories Ltd

What is your opinion about this Stock?

Historical Data

Samco Star Rating Ads

Alpa Laboratories Ltd

118.59 -2.09 (-1.73%)

Brokerage & Taxes at Samco

Brokerage & Taxes at Other traditional broker

Potential Brokerage Savings with Samco ₹ 49.62()

Top Gainers (NIFTY 50)

Stock Name Change %

    Top Losers (NIFTY 50)

    Stock Name Change %

      Open Free Account Now
      Open a Demat Account

      Free Trading & Demat Account

      +91